Page 192 - Read Online

Page 8 of 10 Kaufman et al. J Cancer Metastasis Treat 2019;5:13 I http://dx.doi.org/10.20517/2394-4722.2018.25

the concept of the mobile clinic may bring high-level care directly to communities obviating the need for
[19]
patients to travel long distances to find high-quality healthcare .

In the short-term and long-term, a robust and sustainable solution is the creation of an inclusive culture that
supports the elimination of healthcare disparities and discrimination among different racial, ethnic and
[50]
social groups . The net result would be the replacement of patient isolation in underserved communities
with access to quality healthcare, including access to promising clinical trials to treat cancer.

DECLARATIONS
Authors’ contributions
The authors listed equally contributed to the concept, design, data collection, drafting, revision, and approval
processes of this literature review piece.

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was funded by the U54 UCLA-CDU Partnership to Eliminate Cancer Health Disparities. NCI/
NIH (U54 143931) and NCI/NIH (U54 143930) and the Carl and Roberta Deutsch Foundation.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Randall TC, Armstrong K. Health care disparities in hereditary ovarian cancer: are we reaching the underserved population? Curr Treat
Options Oncol 2016;17:39.
2. Schorge JO, Modesitt SC, Coleman RL, Cohn DE, Kauff ND, et al. SGO White Paper on ovarian cancer: etiology, screening and
surveillance. Gynecol Oncol 2010;119:7-17.
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7-30.
4. Dutta S, Wang FQ, Phalen A, Fishman DA. Biomarkers for ovarian cancer detection and therapy. Cancer Biol Ther 2010;9:668-77.
5. Cohen JG, White M, Cruz A, Farias-Eisner R. In 2014, can we do better than CA125 in the early detection of ovarian cancer? World J Biol
Chem 2014;5:286-300.
6. Brain KE, Smits S, Simon AE, Forbes LJ, Roberts C, et al. Ovarian cancer symptom awareness and anticipated delayed presentation in a
population sample. BMC Cancer 2014;14:171.
7. Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann Oncol 2017; doi: 10.1093/annonc/mdx443.
8. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal
and ovarian (PLCO) cancer screening randomized trial. JAMA 2011;305:2295-303.
9. Chien J, Poole EM. Ovarian cancer prevention, screening, and early detection: report from the 11th biennial ovarian cancer research
symposium. Int J Gynecol Cancer 2017;27:S20-2.
10. Rauh-Hain JA, Krivak TC, Del Carmen MG, Olawaiye AB. Ovarian cancer screening and early detection in the general population. Rev
Obstet Gynecol 2011;4:15-21.
11. Nagle CM. Ovarian cancer epidemiology. In: Schwab M, editor. Encyclopedia of cancer. Berlin, Heidelberg: Springer; 2011.
12. Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, et al. An international assessment of ovarian cancer incidence and mortality. Gynecol
Oncol 2013;130:107-14.